These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 33071757)

  • 1. The Role of Copper in Tau-Related Pathology in Alzheimer's Disease.
    Zubčić K; Hof PR; Šimić G; Jazvinšćak Jembrek M
    Front Mol Neurosci; 2020; 13():572308. PubMed ID: 33071757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
    Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
    Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds.
    Shi H; Zhao Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death.
    Liu M; Sui D; Dexheimer T; Hovde S; Deng X; Wang KW; Lin HL; Chien HT; Kweon HK; Kuo NS; Ayoub CA; Jimenez-Harrison D; Andrews PC; Kwok R; Bochar DA; Kuret J; Fortin J; Tsay YG; Kuo MH
    Mol Neurobiol; 2020 Nov; 57(11):4704-4719. PubMed ID: 32780352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau
    Miao J; Shi R; Li L; Chen F; Zhou Y; Tung YC; Hu W; Gong CX; Iqbal K; Liu F
    Front Aging Neurosci; 2019; 11():34. PubMed ID: 30890929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments.
    Alonso A; Zaidi T; Novak M; Grundke-Iqbal I; Iqbal K
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6923-8. PubMed ID: 11381127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Tsujio I; Grundke-Iqbal I
    J Neural Transm Suppl; 2002; (62):309-19. PubMed ID: 12456074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease.
    Luna-Viramontes NI; Campa-Córdoba BB; Ontiveros-Torres MÁ; Harrington CR; Villanueva-Fierro I; Guadarrama-Ortíz P; Garcés-Ramírez L; de la Cruz F; Hernandes-Alejandro M; Martínez-Robles S; González-Ballesteros E; Pacheco-Herrero M; Luna-Muñoz J
    Front Cell Neurosci; 2020; 14():247. PubMed ID: 33132840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Assembly into Filaments.
    Pérez M; Cuadros R; Medina M
    Methods Mol Biol; 2018; 1779():447-461. PubMed ID: 29886549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.
    Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC
    FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS.
    Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y
    Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation
    Shin SJ; Park YH; Jeon SG; Kim S; Nam Y; Oh SM; Lee YY; Moon M
    Oxid Med Cell Longev; 2020; 2020():7829842. PubMed ID: 32685100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.
    Qureshi HY; Li T; MacDonald R; Cho CM; Leclerc N; Paudel HK
    Biochemistry; 2013 Sep; 52(37):6445-55. PubMed ID: 23962087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models.
    Sarkar S
    J Genet; 2018 Jul; 97(3):783-793. PubMed ID: 30027909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Tau Paired Helical Filaments Differentially Affect Tau Pathogenic Mechanisms in Mitotic and Post-Mitotic Cells: Implications for Mechanisms of Tau Propagation in the Brain.
    Varghese M; Santa-Maria I; Ho L; Ward L; Yemul S; Dubner L; Księżak-Reding H; Pasinetti GM
    J Alzheimers Dis; 2016 Sep; 54(2):477-96. PubMed ID: 27567821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.